Jamie Dananberg
Net Worth
Last updated:
What is Jamie Dananberg net worth?
The estimated net worth of Dr. Jamie Dananberg is at least $1,909,763 as of 31 Mar 2023. He owns shares worth $11,056 as insider, has earned $21,937 from insider trading and has received compensation worth at least $1,876,770 in Unity Biotechnology, Inc..
What is the salary of Jamie Dananberg?
Dr. Jamie Dananberg salary is $625,590 per year as Chief Medical Officer in Unity Biotechnology, Inc..
How old is Jamie Dananberg?
Dr. Jamie Dananberg is 67 years old, born in 1958.
What stocks does Jamie Dananberg currently own?
As insider, Dr. Jamie Dananberg owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Unity Biotechnology, Inc. (UBX) | Chief Medical Officer | 62,817 | $0.18 | $11,056 |
What does Unity Biotechnology, Inc. do?
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
Jamie Dananberg insider trading
Unity Biotechnology, Inc.
Dr. Jamie Dananberg has made 7 insider trades between 2022-2023, according to the Form 4 filled with the SEC. Most recently he sold 420 units of UBX stock worth $714 on 31 Mar 2023.
The largest trade he's ever made was exercising 10,923 units of UBX stock on 14 Sep 2022. As of 31 Mar 2023 he still owns at least 62,817 units of UBX stock.
Unity Biotechnology key executives
Unity Biotechnology, Inc. executives and other stock owners filed with the SEC:
- Dr. Anirvan Ghosh (61) Chief Executive Officer & Director
- Dr. Jamie Dananberg (67) Chief Medical Officer
- Ms. Lynne Marie Sullivan (59) Chief Financial Officer & Head of Corporation Devel.